Comparison of Long-Term Efficacy in S-1 and Capecitabine With Oxaliplatin as Adjuvant Chemotherapy for Patients With Gastric Cancer After Curative Surgery: A Retrospective, Single-Center Observational Study

Comparison of Long-Term Efficacy in S-1 and Capecitabine With Oxaliplatin as Adjuvant Chemotherapy for Patients With Gastric Cancer After Curative Surgery: A Retrospective, Single-Center Observational Study

Purpose: Various adjuvant chemotherapies have been introduced for gastric cancer patients after gastrectomy with D2 lymph node dissection. Although the mainstream regimen of adjuvant chemotherapy in Korea includes S-1 monotherapy (TS-1) and capecitabine with oxaliplatin (XELOX), few studies have com...

Full description

Bibliographic Details
Main Authors: Sung E. Oh MD, Ji Y. An MD, PhD, Min-Gew Choi MD, PhD, Jun H. Lee MD, PhD, Tae S. Sohn MD, PhD, Jae M. Bae MD, PhD
Format: Article
Language:English
Published: SAGE Publishing 2021-09-01
Series:Technology in Cancer Research & Treatment
Online Access:https://doi.org/10.1177/15330338211039679

Internet

https://doi.org/10.1177/15330338211039679

Similar Items